<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03532672</url>
  </required_header>
  <id_info>
    <org_study_id>Acute72774617.6.0000.5149</org_study_id>
    <nct_id>NCT03532672</nct_id>
  </id_info>
  <brief_title>Acute Effect of Fasting</brief_title>
  <official_title>Acute Effect of Fasting Over Metabolic and Inflammatory Responses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of Minas Gerais</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of Minas Gerais</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of the study is to evaluate the acute effects of fasting over inflammatory
      responses.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lean and obese women will fast overnight (10 hours) and will have a standardized breakfast in
      the morning after. The participants will also fast after that meal for more 10 hours during
      the daily activities.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 22, 2017</start_date>
  <completion_date type="Anticipated">May 26, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 26, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Interleukin 6</measure>
    <time_frame>At baseline (after overnight fasting) and end (after 10 hours of fasting during the day) of the intervention period (~12 hours)</time_frame>
    <description>Changes in blood interleukin-6 will be assessed at baseline and after 10 hours of fasting during daily activities</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Resting energy expenditure</measure>
    <time_frame>At baseline (after overnight fasting) and end (after 10 hours of fasting during the day) of the intervention period (~12 hours)</time_frame>
    <description>Changes in resting energy expenditure will be assessed at baseline and after 10 hours of fasting during daily activities using indirect calorimetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lipid panel</measure>
    <time_frame>At baseline (after overnight fasting) and end (after 10 hours of fasting during the day) of the intervention period (~12 hours)</time_frame>
    <description>Changes in lipid panel (i.e. total cholesterol, LDL, HDL and triglycerides) will be assessed at baseline and after 10 hours of fasting during daily activities</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Free fatty acids</measure>
    <time_frame>At baseline (after overnight fasting) and end (after 10 hours of fasting during the day) of the intervention period (~12 hours)</time_frame>
    <description>Changes in free fatty acids will be assessed at baseline and after 10 hours of fasting during daily activities</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood glucose</measure>
    <time_frame>At baseline (after overnight fasting) and end (after 10 hours of fasting during the day) of the intervention period (~12 hours)</time_frame>
    <description>Changes in blood glucose will be assessed at baseline and after 10 hours of fasting during daily activities</description>
  </secondary_outcome>
  <other_outcome>
    <measure>High-sensitivity C-reactive protein</measure>
    <time_frame>At baseline (after overnight fasting) and end (after 10 hours of fasting during the day) of the intervention period (~12 hours)</time_frame>
    <description>Changes in blood high-sensitivity C-reactive protein will be assessed at baseline and after 10 hours of fasting during daily activities</description>
  </other_outcome>
  <other_outcome>
    <measure>Tumor necrosis factor-α</measure>
    <time_frame>At baseline (after overnight fasting) and end (after 10 hours of fasting during the day) of the intervention period (~12 hours)</time_frame>
    <description>Changes in tumor necrosis factor-α will be assessed at baseline and after 10 hours of fasting during daily activities</description>
  </other_outcome>
  <other_outcome>
    <measure>Interleukin 8</measure>
    <time_frame>At baseline (after overnight fasting) and end (after 10 hours of fasting during the day) of the intervention period (~12 hours)</time_frame>
    <description>Changes in blood interleukin 8 will be assessed at baseline and after 10 hours of fasting during daily activities</description>
  </other_outcome>
  <other_outcome>
    <measure>Interleukin 10</measure>
    <time_frame>At baseline (after overnight fasting) and end (after 10 hours of fasting during the day) of the intervention period (~12 hours)</time_frame>
    <description>Changes in blood interleukin 10 will be assessed at baseline and after 10 hours of fasting during daily activities</description>
  </other_outcome>
  <other_outcome>
    <measure>Insulin</measure>
    <time_frame>At baseline (after overnight fasting) and end (after 10 hours of fasting during the day) of the intervention period (~12 hours)</time_frame>
    <description>Changes in insulin will be assessed at baseline and after 10 hours of fasting during daily activities</description>
  </other_outcome>
  <other_outcome>
    <measure>Neutrophil/leukocyte ratio (NLR)</measure>
    <time_frame>At baseline (after overnight fasting) and end (after 10 hours of fasting during the day) of the intervention period (~12 hours)</time_frame>
    <description>Changes in NLR will be assessed at baseline and after 10 hours of fasting during daily activities</description>
  </other_outcome>
  <other_outcome>
    <measure>Appetite sensations</measure>
    <time_frame>At baseline (after overnight fasting) and end (after 10 hours of fasting during the day) of the intervention period (~12 hours)</time_frame>
    <description>Changes in hunger, satiety, fullness, and prospective food consumption will be assessed at baseline and after 10 hours of fasting during daily activities using a 100 mm visual analogue scale</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Healthy</condition>
  <condition>Obese</condition>
  <arm_group>
    <arm_group_label>Acute Fasting</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eutrophic and obese women will fast 10 hours during daily activities after a standardized breakfast.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Acute Fasting</intervention_name>
    <description>The volunteers will fast overnight (10 hours) and breakfast will be offered (bread, butter, ham and industrialized fruit juice) and the participants will fast for more 10 hours during daily activities.</description>
    <arm_group_label>Acute Fasting</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body mass index between 18.5 and 24.9 kg/m² or equal or greater 35 kg/m²;

          -  Able to sign the informed consent.

        Exclusion Criteria:

          -  Chronic health conditions (e.g. chronic renal failure, autoimmune, heart, and, liver
             disease);

          -  Thyroid diseases or medications for its treatment;

          -  Medications known to affect total energy expenditure;

          -  Use of steroids, immunosuppressants, or non-steroidal anti-inflammatory drugs,
             weight-loss medications, oral hypoglycemic agents or insulin, and any medications that
             influence metabolic and/or inflammatory parameters;

          -  Previous surgery for weight loss;

          -  Pregnancy and breast-feeding;

          -  Smoking;

          -  Alcohol use (&gt;2 doses/day).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Adaliene Versiani Matos Ferreira, PhD</last_name>
    <phone>+553134093680</phone>
    <email>adaliene@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Adaliene Versiani Matos Ferreira, adaliene@gmail.com</last_name>
    <phone>+553134093680</phone>
    <email>adaliene@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital das Clínicas</name>
      <address>
        <city>Belo Horizonte</city>
        <state>Minas Gerais</state>
        <zip>30130-100</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adaliene VM Ferreira, PhD</last_name>
      <phone>+553134093680</phone>
      <email>adaliene@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 7, 2018</study_first_submitted>
  <study_first_submitted_qc>May 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2018</study_first_posted>
  <last_update_submitted>May 19, 2018</last_update_submitted>
  <last_update_submitted_qc>May 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of Minas Gerais</investigator_affiliation>
    <investigator_full_name>Adaliene Versiani M. Ferreira</investigator_full_name>
    <investigator_title>Principal Investigator, Associate Professor, PhD</investigator_title>
  </responsible_party>
  <keyword>Acute fasting</keyword>
  <keyword>Inflammatory response</keyword>
  <keyword>Energy Expenditure</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

